RETRACTED: Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein
- 1 January 2006
- journal article
- retracted article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 38 (8) , 1417-1428
- https://doi.org/10.1016/j.biocel.2006.02.003
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Biochemical and immunological studies of nucleocapsid proteins of severe acute respiratory syndrome and 229E human coronavirusesProteomics, 2005
- The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domainBiochemical and Biophysical Research Communications, 2004
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- Up-regulation of p300 Binding and p50 Acetylation in Tumor Necrosis Factor-α-induced Cyclooxygenase-2 Promoter ActivationPublished by Elsevier ,2003
- Dynamic Regulation of Cyclooxygenase-2 Promoter Activity by Isoforms of CCAAT/Enhancer-binding ProteinsJournal of Biological Chemistry, 2002
- Localization to the Nucleolus Is a Common Feature of Coronavirus Nucleoproteins, and the Protein May Disrupt Host Cell DivisionJournal of Virology, 2001
- Selective Suppression of CCAAT/Enhancer-binding Protein β Binding and Cyclooxygenase-2 Promoter Activity by Sodium Salicylate in Quiescent Human FibroblastsJournal of Biological Chemistry, 2001
- Transcriptional Regulation of Cyclooxygenase-2 in Mouse Skin Carcinoma CellsJournal of Biological Chemistry, 1998
- HIV-1 gp120-Induced Apoptosis in the Rat Neocortex Involves Enhanced Expression of Cyclo-oxygenase Type 2 (COX-2)Biochemical and Biophysical Research Communications, 1998